Research Article

Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens

Table 5

Mobilograph measurement indices.

Control ()Patient ()

pSBP (mmHg)116.7 ± 16.1123.3 ± 11.90.050
pDBP (mmHg)73.4 ± 1483 ± 10.60.001
pMAP (mmHg)92.3 ± 13.2102.2 ± 12<0.001
bPP (mmHg)42.1 ± 13.943.5 ± 10.70.66
cSBP (mmHg)108.6 ± 16.3114.9 ± 150.090
cDBP (mmHg)74.8 ± 1484.5 ± 10.60.001
aPP (mmHg)33.8 ± 9.130.4 ± 10.10.144
CO (L/min)4.1 ± 0.54.4 ± 0.70.077
Peripheral resistance1.2 ± 0.11.3 ± 0.20.160
CI (L/m2 × 1/m2)2.2 (1.7 to 3)2.4 (2 to 5.6)0.074
Augmentation pressure7.4 ± 67.3 ± 4.10.868
Augmentation index23.5 (−19 to 42)29.5 (1 to 53)0.010
CO4 (3.2 to 5.5)4.4 (3.3 to 8.3)0.050
Pulse wave velocity5.8 ± 1.47.3 ± 1.2<0.001

pSBP: peripheral systolic blood pressure; pDBP: peripheral diastolic blood pressure; pMAP: periferic mean arterial pressure; bPP: brachial pulse pressure; cDBP: central diastolic blood pressure; cSBP: central systolic blood pressure; aPP: aortic pulse pressure; CO: cardiac output; CI: cardiac index.